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Obstetric Perinatal Mortality Review 
 
From January 2002 through June 2003, the obstetric half of the perinatal team 
collected information on stillbirths (fetal deaths) and neonatal deaths at the time of 
hospital visitations across the state.  All levels of care were represented.  The purpose of 
this communication is to review the causes of fetal/neonatal death identified and to 
comment on cases which were potentially preventable or which reflected suboptimal 
care.  It must be emphasized that the reviewers had the benefit of hindsight, brought their 
individual attitudes as to what constitutes appropriate care, and do not know with 
certainty that, if care had been modified, the outcome would have been any different.  
Nevertheless, large numbers of deaths were reviewed and some assessment can be made 
as to areas of potential preventability and to areas of obstetric care which can be 
improved. 
 Three hundred forty-four perinatal deaths were studied.  Two-thirds of these were 
fetal deaths and one-third neonatal deaths.  Singleton pregnancies represented 84 percent 
of the deaths with products of multiple gestation accounting for 16 percent.  Since 
products of multiple gestation constitute approximately 3 percent of Iowa live births, one 
can see the disproportionate risk of perinatal loss associated with multiples.   
 Multiple Gestation   
Fifty-six deaths occurred in multiple gestation pregnancies.  The significance of 
early preterm delivery is highlighted by the fact that 63 percent of the mortality occurred 
under 24 weeks’ gestation.  Early preterm labor and functional cervical incompetence are 
the most significant problems in multiple gestation pregnancies.   
Fourteen, or one-quarter, of the deaths occurred in the third trimester.  Twin-twin 
transfusion, cord accidents including those in monoamniotic twins, intrauterine growth 
restriction and congenital malformations were represented. 
Singleton Pregnancies 
 There were 288 perinatal deaths in singleton pregnancies, 210 of these 
represented fetal deaths, and 78 were neonatal deaths.   
Fetal deaths 
 Of the 210 fetal deaths reviewed, 22 percent occurred at less than 24 weeks’ 
gestation.  Some of these occurred prior to labor and others as a result of the stress of the 
preterm labor.  The most common cause of fetal death at or after 24 weeks’ gestation was 
“unknown”.  This unknown category comprised 41 percent of the 164 deaths.  Many 
deaths wound up in the unknown category, because no evaluation of the stillbirth was 
undertaken.  Others remained without explanation despite extension evaluation.  A 
protocol for the evaluation of fetal deaths was published in The Iowa Perinatal Letter, 
volume XXIII, #2, April/May/June 2002.  Cord or placental factors were implicated in 22 
percent of the deaths at or after 24 weeks’ gestation, intrauterine growth restriction in 12 
percent, congenital malformations in 11 percent, and an “other” category in 14 percent. 
 The “other” category included non-immune hydrops, diabetes, fetomaternal hemorrhage, 
and preeclampsia.   
Neonatal deaths 
 Seventy-eight neonatal deaths occurred in singleton pregnancies.  More than one-
third of these were delivered at less than 24 weeks’ gestation.  Thirty-six of the neonatal 
deaths occurred in pregnancies which ended in the third trimester.  Twenty neonates were 
anomalous and 10 newborns suffered from fetal distress/birth asphyxia (non-immune 
hydrops, placental abruption, maternal death, and diabetes were represented). 
Suboptimal Care 
 The physician and nurse reviewer identified suboptimal care in 8.4% of the 344 
perinatal deaths reviewed.  Eight instances of “preventability” were ascribed to the 
patient.  No prenatal care and drug abuse were common.  There were 21 cases in which 
suboptimal care was ascribed to the physician or nurse.  These will now be considered.   
Poorly controlled diabetes – N=4 
 The hallmark of managing diabetes in pregnancy is good blood glucose control.  
It is desirable to have fasting sugars less than 95, two-hour postprandial sugars less than 
120, and one-hour postprandial sugars less than 140.  This is true for both gestational and 
pre-gestational diabetics.  If a woman with diabetes requires more than diet for blood 
sugar control, tests of fetal well-being should be employed in late pregnancy.  Even if this 
testing is normal, and the blood sugar control is good, these patients should probably be 
delivered prior to their due dates.  Two of these four deaths occurred after the EDD.  Poor 
blood sugar control and/or abnormal fetal well-being testing would indicate an earlier 
delivery. 
No cervical surveillance in twins – N=4 
 Women with multiple gestation pregnancies are at risk for delivery in mid-
gestation.  Our recommended practice in this situation is to follow the cervix with 
transvaginal determinations of cervical length biweekly from 16-24 weeks’ gestation.  If 
cervical shortening is identified (lengths less than 20-25 mm), intervention is called for.  
Activity restriction, tocolytic therapy, cervical cerclage, or transfer to a perinatal center 
might be considered depending on individual circumstances. 
Inappropriate reaction to non-reactive non-stress test at term – N=4 
 As stressed in The Iowa Perinatal Letter, volume XXIV, #4 – 
October/November/December 2003, a non-reactive non-stress test at term, not explained 
by congenital malformation or maternal medication, generally means that delivery should 
be effected.  The urgency of delivery is determined in part by other features of the tracing 
(baseline variability, presence of decelerations).  If the tracing is worrisome, move 
quickly. 
Slow response to fetal distress in labor – N=3 
 Physicians and nurses both should be able to identify distress patterns on the 
monitor and to respond appropriately. 
Recording maternal, not fetal heart rate – N=2 
 It is important for nurses, when providing care in the labor room, to be certain that 
indeed it is the fetal heart rate that is being represented on the monitor.  In these two 
cases, the monitor looked “fine”, but very depressed babies were delivered.  In retrospect, 
the fetal heart rate was not what was being recorded. 
Failure to identify intrauterine growth restriction – N=2 
 Conscientiously determine fundal heights at each visit.  In the woman of normal 
size, if fundal heights do not seem appropriate, order an ultrasound to try to identify 
growth restriction.  In the obese patient fundal heights are of limited value.  In the obese 
patient with significant hypertension, get an ultrasound for growth to be certain that 
growth restriction is not missed. 
Failure to deliver the woman with pre-eclampsia at term –N=1 
 Although patients with gestational hypertension at term can be treated expectantly 
with close follow-up, patients with genuine pre-eclampsia at term generally should be 
delivered. 
Doptone response to decreased fetal movement –N=1 
 If a woman complains of decreased fetal movement from the time when the fetus 
is potentially viable, (23-24 weeks’ gestation), the response to the complaint should be to 
order a non-stress test.  Doptone evaluation can identify that the fetus is alive, but not 
necessarily that the fetus is healthy. 
Conclusion 
 Periodically, obstetric perinatal mortality reviews have been reported in The Iowa 
Perinatal Letter for the past quarter century.  Over the years clear improvements in 
obstetric care have been noted.  As indicated in the preceding paragraphs, however, we 
can and should do better. 
 - Frank J. Zlatnik, M.D.-Kathryn R. Papke, R.N. 
 
Neonatal Polycythemia/Hyperviscosity Syndrome 
 Neonatal polycythemia is a significant potential source of morbidity and an issue 
confronting every clinician providing newborn care.  Historical descriptions of plethoric 
infants abound, heralding back to biblical times with the description of what some 
suspect detail Isaac and Rebekah’s monochorionic twin pregnancy with “red” Esau born 
followed by Jacob who arrives holding onto his brother’s heel.  Case reports and 
publications surfaced in the 1950s describing infants with convulsions, cyanosis, 
respiratory distress, and cardiovascular strain associated with plethora and high 
hematocrits.  Most of these infants were treated with observation and supportive care 
while some underwent therapeutic phlebotomy.  The medical management of 
polycythemic infants with subsequent trials of intervention created the foundation for our 
current evidence-based practice.  The purpose of this brief article is to review neonatal 
polycythemia with respect to the physiologic basis and risk factors, symptoms and 
diagnostic criteria, potential morbidities, and finally, treatment. 
 The definition of neonatal polycythemia often seems elusive as it may include 
infants with and without symptoms having hematocrits ranging from 60 percent to greater 
than 70 percent.  The reported incidence of polycythemia ranges from 0.4 to 12 percent in 
newborns, making it a likely candidate in every newborn nursery.  Considering the 
potential sequelae of polycythemia, which include pulmonary hypertension, congestive 
heart failure, hypoxemia, myocardial strain, thromboses, gangrene, and stroke – it should 
not be overlooked. 
 Fetal red blood cells (RBC) have a larger mean cell volume and are less 
deformable than more mature cells, leading to increased viscosity.  The relatively 
hypoxic in utero environment induces RBC production leading to an increased RBC mass 
at birth and thus a relatively polycythemic state.  It is the combination of these two 
scenarios that led to the descriptive term of polycythemia/hyperviscosity syndrome.  It is 
the effects of the hyperviscosity that can ultimately be most devastating. 
 The initial research done in neonatal polycythemia utilized a viscometer to 
measure how easily blood could flow.  These studies displayed a fairly linear relationship 
between viscosity and RBC mass with hematocrits less than 60-65 percent.  Once the 
hematocrit exceeded 60-65 percent, viscosity increased exponentially.  Thus, the only 
marker in current use today (hematocrit) may under-represent the degree of 
hyperviscosity for many polycythemic infants.  Interestingly, the initial studies also 
identified a significant correlation between an umbilical cord hematocrit above 56 
percent and an infant hematocrit greater than 70 percent at two hours of age. 
 As laboratory equipment such as centrifuges became readily available in the 
office and nursery setting, spun hematocrits replaced determination of viscosity for 
diagnosis of polycythemia and thus, by inference, of hyperviscosity.  Newer technology 
has now replaced the spun hematocrit in many nurseries, providing an automated 
determination of hematocrit by calculating the mean RBC volume and hemoglobin.  This 
current method provides lower values for hematocrit when compared to the 
centrifugation method and thus may under-represent the frequency of clinically important 
polycythemia. 
 Polycythemia may occur in a number of clinical scenarios.  Infants of diabetic 
mothers or those who experienced placental insufficiency in utero (i.e., preeclampsia, 
maternal smoking, maternal heart disease or maternal use of propranolol, SGA/LGA 
infants) may be polycythemic at birth in response to chronic hypoxia.  The incidence of 
polycythemia ranges from 22-29 percent in infants of poorly controlled diabetic mothers.  
Twin-twin transfusion and genetic syndromes (such as the trisomies 13, 18, and 21 and 
Beckwith-Wiedemann) as well as neonatal thyrotoxicosis, congenital adrenal hyperplasia, 
and hypothyroidism are also associated with neonatal polycythemia.  Certainly, no 
specific underlying cause or predisposition can be identified in many cases. 
 Part of the postnatal adjustment following delivery involves shifts in intra- and 
extracellular fluid leading to a peak in the hematocrit between two and six hours of age.  
It is always appropriate to obtain a capillary hematocrit in the ruddy, high-risk, or 
symptomatic infant to screen for neonatal polycythemia.  This method may overestimate 
the central hematocrit by 5-15 percent as sludging or sampling from a suboptimally 
perfused extremity may yield falsely elevated values.  Thus, a capillary hematocrit value 
above 65 percent warrants repeating by venipuncture.  If the venous sample has a value 
between 65-70 percent, the clinician must decide on further intervention based on the 
presence or absence of associated symptoms; treating if symptoms exist.  Symptoms of 
polycythemia include respiratory distress, tachypnea, hypoglycemia, tremulousness, 
lethargy, irritability, apnea, seizures, jitteriness, poor feeding, weak suck, and cyanosis. 
 Clinical studies and observations have provided us with guidelines for the 
treatment of infants with neonatal polycythemia.  The symptomatic infant with a venous 
hematocrit greater than 65 percent or arterial value greater than 63 percent warrants 
intervention.  (Some suggest that the symptomatic infant with a venous hematocrit 
greater than 60 percent likewise warrants intervention – this must be decided on a case-
by-case basis.)  The asymptomatic infant with a venous hematocrit value of 70 percent or 
greater needs intervention.  Thus, serum glucose, blood gas, pulse oximetry, serum 
platelet count, and calcium should be obtained to screen for hypoglycemia, 
hypoventilation or hypoxemia, thrombocytopenia, and hypocalcemia, all of which can be 
associated with polycythemia, and these conditions must be addressed if present.  If the 
infant is between the age of 24-48 hours and dehydration is suspected, serum sodium, 
blood urea nitrogen, and urine specific gravity may aid in the diagnosis.  Serum bilirubin 
should also be monitored closely as polycythemic infants are likely to have increased 
turnover of red blood cells leading to increased production and accumulation of bilirubin. 
 If the venous hematocrit is less than 65 percent in an asymptomatic infant who is 
already six hours old, no further evaluation is needed.  A repeat venous hematocrit should 
be obtained in infants of less than six hours to avoid false reassurance prior to the time of 
peak hematocrit values.  If dehydration is diagnosed in the first few days of life, a trial of 
rehydration may be attempted for 6-8 hours.  The hematocrit should be followed during 
this period and assessed every 4-6 hours.  If the venous hematocrit is 65-70 percent in the 
asymptomatic infant, observation and serial assessment of the hematocrit with adequate 
hydration is appropriate. 
 For the infant with symptoms consistent with polycythemia or with a central 
hematocrit greater than 70 percent, a partial exchange transfusion is indicated.  
Historically, many fluids have been used in the partial exchange, including normal saline, 
5 percent albumin, and fresh frozen plasma.  Because the use of blood products has not 
been demonstrated to offer significant benefit and because there is risk of infection from 
a donated human product, we use normal saline for the partial exchange transfusion.  The 
amount of blood to exchange for normal saline is calculated to each a final central 
hematocrit of 50-55 percent, using an estimated blood volume of 80 cc/kg. 
 
Vol exchanged (mL) = [Weight (kg) x blood vol] x [Hct of patient – desired Hct] 
Hct of patient 
 
 Thus, a 4 kg infant with a central hematocrit of 70 percent would need 69-90 cc of 
saline exchanged for removed blood to achieve a post-procedure central hematocrit of 50-
55 percent.  We recommend drawing a hematocrit form the umbilical catheter prior to the 
exchange and basing calculations on this value if it is significantly different from the 
peripheral venous sample.  We typically withdraw blood slowly from a low-lying 
umbilical venous catheter (inserted to 4 cm or where good blood return is first obtained) 
and simultaneously infuse normal saline through a 24 or 22 gauge peripheral IV.  We 
discourage the “push-pull” technique of withdrawing aliquots of blood and then infusing 
through the same umbilical catheter, as this has been associated with an increased 
incidence of post-procedure necrotizing enterocolitis.  We provide maintenance hydration 
needs with an intravenous dextrose solution and delay feeding for 4-6 hours after the 
exchange to allow normalization of gastrointestinal blood flow. 
 The partial exchange transfusion, though potentially lifesaving, is not without risk 
and requires intensive monitoring during and following the procedure.  Laboratory 
studies such as calcium, glucose, hematocrit, and platelet count would be obtained before 
and after the exchange.  If the infant displays symptoms suggestive of sepsis, coverage 
with ampicillin and gentamicin is warranted.  Post-procedure antibiotic prophylaxis is 
controversial as infection is uncommon, however, it is the most frequent complication of 
the procedure.  Other complications include necrotizing enterocolitis, coagulopathies 
(from thrombocytopenia or diminished coagulation factors), hypoglycemia, and 
hypocalcemia.  In settings where support personnel may be less familiar with the 
procedure and necessary monitoring, it is important to consider the initiation of adequate 
intravenous hydration and to arrange transport of the infant to a center with 
neonatologists and the nursing support required for medical intervention. 
 In summary, high-risk and symptomatic infants should be screened for 
polycythemia.  If neonatal polycythemia is confirmed on venous sampling, treatment 
must be initiated or transport arranged to a treating facility. 
 -Nicole Schmidt, M.D. 
 Neonatologist in Private Practice 
 Portland, Oregon 
 
